Target intelligence / Profile preview

RB binding protein 4 pseudogene 3 (RBBP4P3)

Target
RBBP4P3
Molecular classification
Other (pseudogene; not an active protein-coding gene)
01

Overview

RB binding protein 4 pseudogene 3 (RBBP4P3) is a pseudogene, not a protein-coding gene, and therefore does not produce a functional protein product or serve as a direct therapeutic or pharmacological target. Its name and annotation stem from genomic similarity to the genuine RBBP4 gene, which codes for retinoblastoma binding protein 4—a chromatin-associated protein involved in cell cycle regulation, chromatin remodeling, histone modification, and tumor suppression[2][3][5]. However, RBBP4P3 has not been shown to encode a receptor, enzyme, transporter, or other druggable target class, and there is no scholarly evidence to support it being a target in disease or therapy. RBBP4P3 should not be confused with RBBP4, an active protein recognized for its role in the NuRD complex, MuvB/DREAM cell cycle regulatory complexes, and histone modification machinery[2][3][5]. The inclusion of "pseudogene" in the name indicates this locus is presumably transcriptionally or translationally inactive and not involved in encoding functional proteins. If you require information about the active protein RBBP4, please clarify, as that molecule is a well-studied epigenetic modulator and candidate target in oncology and developmental biology[2][3][5]. For RBBP4P3, there is no evidence of functional relevance in any molecular, cellular, or therapeutic context.

Other names
RBBP4 pseudogene 3RB binding protein 4 pseudogene 3Retinoblastoma binding protein 4 pseudogene 3RBBP4P3

Beyond the preview

Go deeper on RB binding protein 4 pseudogene 3 (RBBP4P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RB binding protein 4 pseudogene 3 (RBBP4P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call